Ronald Bracken is the Chief Executive Officer at RenovoDerm, LLC. A proven life sciences executive, entrepreneur and inventor, Mr. Bracken currently serves as the CEO of Paragen Technologies, LLC and its commercial subsidiaries, RenovoDerm, LLC and Atreon Orthopedics, LLC. Prior to his role as CEO, Ronald served as the Chief Operating Officer for Paragen Technologies, as a co-founder of the Paragen companies, and Chief Operating Officer of Nanofiber Solutions, LLC. Prior to joining the Company, led Research and Development for C.R. Bard as Global Vice President. His experience includes 30+ years of product development, strategic mergers & acquisitions and commercialization initiatives, launching numerous new technology platforms throughout his career. Mr. Bracken holds a Bachelor of Science degree in Polymer Science from the University of Southern Mississippi.
Hilary Dixon joined RenovoDerm in June 2024 as the Company’s Chief Commercial Officer. Ms. Dixon brings 20+ years of experience in Product Management, Commercialization and Strategic Marketing, spanning Medtech and Biotech industries. Prior to joining RenovoDerm, Ms. Dixon served as Vice President, Corporate & Strategic Communications at MiMedx; prior to this role, she led Marketing initiatives for the Surgical, Spine & Orthopaedic market for MiMedx. Prior to joining MiMedx, Ms. Dixon served as Strategic Marketing Manager at C. R. Bard, with responsibility for upstream marketing, including integration of a recent acquisition and ongoing strategic due diligence. She additionally held positions of increasing responsibility at Medtronic Spine and Biologics, launching multiple spinal systems across broad therapeutic applications. Ms. Dixon holds a both a Bachelor of Science and Master of Science in Industrial Engineering from the Georgia Institute of Technology.